Macgest SR 300 Tablet contains Progesterone (Natural Micronized) 300 mg, a vital hormone used primarily in hormone replacement therapy and the management of various gynecological conditions. Progesterone is essential for regulating the menstrual cycle, maintaining pregnancy, and supporting endometrial receptivity. This sustained-release formulation ensures a gradual and consistent release of progesterone, enhancing therapeutic efficacy and patient compliance. Macgest SR 300 is indicated for the treatment of progesterone deficiency states such as luteal phase support in assisted reproductive technology (ART), prevention of threatened miscarriage, and management of secondary amenorrhea. It is also utilized in hormone replacement therapy to counteract estrogen-induced endometrial hyperplasia in menopausal women. The natural micronized form improves bioavailability and mimics endogenous progesterone activity. Administration should follow medical guidance, with dosage tailored to the specific condition and patient response. Common side effects may include headache, breast tenderness, dizziness, and mild gastrointestinal disturbances. Contraindications include known hypersensitivity to progesterone, unexplained vaginal bleeding, active thromboembolic disorders, and hormone-dependent malignancies. Regular monitoring is advised during therapy to assess efficacy and detect adverse effects. Macgest SR 300 Tablet is a reliable option for restoring hormonal balance and supporting reproductive health under professional supervision.